EFPIA - NEWSLETTER

Trouble reading this email? View it in your browser


		EFPIA Newsletter 28 October 2021

News

Joint Industry Statement: ABPI, EFPIA, Farmindustria, IMC, IFPMA, JPMA, LEEM, PhRMA, vfa
28 October 2021

UN Climate Change Conference (COP26): Biopharmaceutical Industry Actions to Tackle Climate Change Read more

Supporting academic and non-for-profit champions to repurpose medicines
28 October 2021

The EMA and several National Competent Authorities launch a new pilot project today Read more

Good Lay Summary Practice Recommendations are now published in EudraLex.
27 October 2021

Recognising the importance of providing accessible and understandable summaries of clinical trial results to patients... Read more

Blogs

Fitting vaccine research into one year – Were animals used?
27 October 2021 - Kirsty Reid - Philippe Juvin - Jean Lang

A blog by EFPIA and Vaccines Europe Read more

#EUnited against inequalities in Cancer care
27 October 2021 - Lamis Chahoud

From the EU Beating Cancer Plan to the countries where patients live and receive care Read more

Living with cancer after cancer (Guest Blog)
28 October 2021

We as a society are all responsible for comprehensive inclusion and return of cancer patients to normal life after treatment... Read more

Making the impossible, possible

Finding personalised solutions for each person living with allergies
Precision medicine can make it possible to find personalised solutions for each person living with allergies, thus improving... Read more

Pushing the boundaries of science
Every journey begins with a question. The urge to find the answer drives us to search for new ways to push the boundaries... Read more

Events

Global Pharmaceutical and Biotechnology Conference
08 November 2021 (Virtual event)

Sustaining innovation and collaboration beyond the pandemic #FTPharma Read more

Investigating the syndemic threat of COVID-19 and chronic disease: The diabetes case
09 November 2021 (Virtual event)

Improved integration of care is the way forward to strengthen chronic disease management in emergencies and beyond Read more

Joint EFPIA & EFGCP “Good Lay Summary Practice” Recommendations
09 November 2021 (Virtual event)

The new tool you should use to comply with the European Clinical Trial Regulation (EU No. 536/2014) Read more

Pandemic Prevention: how Europe can lead the fight against AMR
16 November 2021 (Virtual event)

The COVID-19 pandemic took the world by surprise. An AMR induced pandemic will not. Read more

What we are reading

EU Hits 75% COVID-19 Vaccine Uptake
On 19 October 2021 (Vaccines Today)

Exclusive interview: we ask the EU Commissioner for Health about vaccine uptake, online misinformation, getting routine... Read more

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
E-mail:Communications@efpia.eu